{
  "meta": {
    "title": "49_Sleep_Apnea",
    "url": "https://brainandscalpel.vercel.app/49-sleep-apnea-f67cdf3b.html",
    "scrapedAt": "2025-11-30T12:28:48.699Z"
  },
  "questions": [
    {
      "text": "Sleep apnea is defined as a temporary pause in breathing during sleep lasting at least :",
      "choices": [
        {
          "id": 1,
          "text": "30 seconds"
        },
        {
          "id": 2,
          "text": "20 seconds"
        },
        {
          "id": 3,
          "text": "15 seconds"
        },
        {
          "id": 4,
          "text": "10 seconds"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Sleep apnea is defined as a<strong> temporary pause</strong> in breathing during sleep lasting at least <strong>10 seconds</strong>.</p>\n<p>Sleep apneas can be further divided into:</p>\n<ol>\n<li><strong>Obstructive</strong> apneas - Sleep apnea with persistent respiratory effort.</li>\n<li><strong>Central</strong> apneas - Sleep apnea with an absence of respiratory effort.</li>\n</ol>\n<p>The <strong>gold standard</strong> for the diagnosis of obstructive sleep apnea/hypopnea syndrome (OSAHS) is an <strong>overnight polysomnogram</strong> (PSG).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3368",
      "difficulty": "medium"
    },
    {
      "text": "A patient is referred to the sleep clinic for polysomnography. Which of the following is not a component of it?",
      "choices": [
        {
          "id": 1,
          "text": "EEG"
        },
        {
          "id": 2,
          "text": "Skeletal muscle activation"
        },
        {
          "id": 3,
          "text": "Peripheral pulse oximetry"
        },
        {
          "id": 4,
          "text": "Arterial blood gases"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Arterial blood gases</strong> are not part of polysomnography. However, they are usually measured to rule out<strong> alveolar hypoventilation</strong> secondary to lung disease or chest wall abnormalities.</p>\n<p>An overnight <strong>polysomnogram</strong> is a multi-parametric test and is the <strong>gold standard</strong> for the diagnosis of obstructive sleep apnea. It includes:</p>\n<ul>\n<li><strong>EEG</strong></li>\n<li>Eye movements (EOG)</li>\n<li><strong>Muscle activity or&nbsp;skeletal muscle activation (EMG)</strong></li>\n<li>ECG</li>\n<li>Respiratory airflow and respiratory effort indicators</li>\n<li><strong>Peripheral pulse oximetry</strong></li>\n<li>Sleep latency</li>\n<li>Sleep efficiency</li>\n<li>Arousal index</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f42d580177c6405fbb97e3d1119839bfx1280x1919.JPEG\" alt=\"Explanation Image\"><p>Other sleep disorders diagnosed by polysomnography:</p>\n<ul>\n<li>Narcolepsy</li>\n<li>Idiopathic hypersomnia</li>\n<li>Periodic limb movement disorder</li>\n<li>REM behavior disorder</li>\n<li>Parasomnias</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3373",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged obese patient presented with complaints of daytime tiredness and decreased exercise tolerance. Echocardiology revealed reduced ejection fraction. The sleep study showed periods of apnea without respiratory efforts. Which of the following is not true regarding his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Transient cessation of neural drive to all respiratory muscles"
        },
        {
          "id": 2,
          "text": "Associated with Cheyne Stokes breathing"
        },
        {
          "id": 3,
          "text": "Is due to decreased sensitivity to pCO2"
        },
        {
          "id": 4,
          "text": "Can be induced by CPAP at high pressure"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>central sleep apnea</strong> (CSA), and it is caused by<strong> increased sensitivity to pCO2</strong>.<strong><sub>&nbsp;</sub></strong>Thus changes in pCO2 levels during sleep lead to an unstable breathing pattern that manifests as hyperventilation alternating with apnea.&nbsp;Crescendo-decrescendo breathing pattern known as <strong>Cheyne-Stokes respiration</strong> is seen.</p>\n<p>Risk factors for CSA:</p>\n<ul>\n<li><strong>Heart failure</strong></li>\n<li>Opioid medications&nbsp;</li>\n<li>Hypoxia (e.g., breathing at high altitude)</li>\n<li>Continuous positive airway pressure (CPAP) at high pressures seems to induce central apnea; this condition is referred to as <strong>complex sleep apnea</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3369",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following drugs is not a risk factor for the development of central sleep apnea?",
      "choices": [
        {
          "id": 1,
          "text": "Opioids"
        },
        {
          "id": 2,
          "text": "Strychnine"
        },
        {
          "id": 3,
          "text": "Barbiturates"
        },
        {
          "id": 4,
          "text": "Gelsemium"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Strychnine</strong> is not a risk factor as it does not cause respiratory depression. It is a <strong>CNS stimulant</strong>. Only drugs that cause <strong>respiratory centre depression</strong> are risk factors for the development of <strong>central sleep apnea</strong>.</p>\n<p>Option A: <strong>Opioids</strong> depress the respiratory centre in a dose-dependent manner.</p>\n<p>Option C: <strong>Barbiturates</strong> cause respiratory depression in high doses.</p>\n<p>Option D: <strong>Gelsemium</strong> is an ergot-type alkaloid and is a CNS depressant. Often used in homoeopathy, in large doses, paralysis and death from respiratory failure can occur.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/54c34c118bf94acca18594a775ab350cx664x361.PNG\" alt=\"Explanation Image\"><p>The pink shaded area shows an apneic period without any respiratory efforts.</p><hr><h3>Related Pearl: CNS Stimulants and Depressants</h3><table>\n<tbody>\n<tr>\n<td><strong>CNS stimulants</strong></td>\n<td><strong>CNS depressants</strong></td>\n</tr>\n<tr>\n<td>\n<p>Directly acting on CNS:</p>\n<ul>\n<li>Cortical: Caffeine, Aminophylline, Amphetamine, Ephedrine</li>\n<li>Medullary: Picrotoxin, Adrenaline</li>\n<li>Spinal: Strychnine, Brucine</li>\n</ul>\n<p>Reflexly acting on CNS:</p>\n<ul>\n<li>Nicotine, Lobetine</li>\n</ul>\n</td>\n<td>\n<p>Sedatives: Diazepam, Oxazepam</p>\n<p>Hypnotics: Clonazepam, Nitrazepam</p>\n<p>Alcohol: Dose dependant sedative-hypnotic</p>\n<p>Narcotics: Morphine, Codeine</p>\n<p>General anesthetics: Barbiturates, Halothane</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3370",
      "difficulty": "medium"
    },
    {
      "text": "A patient comes to the sleep clinic and the following pattern is seen on polysomnography. What type of breathing pattern is it?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperventilation respiration"
        },
        {
          "id": 2,
          "text": "Cheyne-Stokes respiration"
        },
        {
          "id": 3,
          "text": "Kussmaul's respiration"
        },
        {
          "id": 4,
          "text": "Biot's respiration"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The breathing pattern shown in the image is suggestive of <strong>Cheyne-Stokes respiration</strong>. It is characterized by progressively deeper and sometimes faster breathing, followed by a gradual decrease that results in a temporary stop in breathing called apnea.</p>\n<p>It is caused by an<strong> increased sensitivity </strong>of the respiratory center to<strong> arterial PCO<sub>2</sub></strong>. There is an apneic phase, during which arterial PO<sub>2</sub> falls and arterial PCO<sub>2</sub> rises. These changes in the arterial blood gas content stimulate the respiratory center, resulting in hyperventilation and hypocapnia, followed by recurrence of apnea. It is present in 40% of patients with <strong>advanced HF</strong> and usually is associated with low cardiac output.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4487a95715b74bbfab7d2f4f2aae2bd4x1280x2311.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4a511af3d36e414390406b6a5b62c1a3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3371",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old man presents with daytime sleepiness and impaired concentration and memory. On examination, his BMI is 41 kg/m2, blood pressure is 160/100 mm of Hg. His awake arterial blood gas analysis is given below. What is the most likely diagnosis?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Parameter</td>\n<td>Value</td>\n</tr>\n<tr>\n<td>PaO2</td>\n<td>66mmHg</td>\n</tr>\n<tr>\n<td>PaCO2</td>\n<td>50mmHg</td>\n</tr>\n<tr>\n<td>HCO3</td>\n<td>30mEq/L</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Obstructive sleep apnea"
        },
        {
          "id": 2,
          "text": "Narcolepsy"
        },
        {
          "id": 3,
          "text": "Obesity hypoventilation syndrome"
        },
        {
          "id": 4,
          "text": "Central sleep apnea"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most probable diagnosis of this patient is <strong>obesity hypoventilation syndrome</strong>.</p>\n<p>Obesity hypoventilation syndrome (OHS) or Pickwickian syndrome is defined as the presence of&nbsp;<strong>awake</strong>&nbsp;<strong>alveolar hypoventilation</strong> in an <strong>obese</strong> individual which cannot be attributed to other conditions associated with alveolar hypoventilation.</p>\n<p>Patients with OHS are obese and give a history of daytime hypersomnolence, loud snoring, choking during sleep, fatigue, impaired concentration, and memory. On examination usually, there is a small oropharynx and a thick neck.</p>\n<p>OHS may be associated with the following findings:</p>\n<ul>\n<li>Elevated serum bicarbonate (&gt;27&nbsp;<span class=\"nowrap\">mEq/L)</span></li>\n<li>Hypercapnia (PaCO<sub>2</sub>&nbsp;&gt;45 mmHg)</li>\n<li>Hypoxemia (PaO<sub>2</sub>&nbsp;&lt;70 mmHg)&nbsp;</li>\n<li>Polycythemia&nbsp;</li>\n</ul>\n<p>Options A and D: In obstructive sleep apnea and central sleep apnea, the <strong>awake ABG</strong> values are usually <strong>normal</strong>.</p>\n<p>Option B: There are no ABG changes in narcolepsy.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0638",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old man is brought to the OPD by his wife for gasping episodes during sleep and excessive daytime sleepiness. She reported that he even dozed off while driving yesterday and nearly caused an accident. He is being treated for hypertension, gastro-oesophageal reflux, and type 2 diabetes. What else would be the ideal therapy for his symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Supplemental oxygenation therapy"
        },
        {
          "id": 2,
          "text": "Uvulopalatopharyngoplasty"
        },
        {
          "id": 3,
          "text": "Continuous positive airway pressure therapy"
        },
        {
          "id": 4,
          "text": "Implantable neuro-stimulation of the hypoglossal nerve"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario suggests a diagnosis of obstructive sleep apnea/hypopnea syndrome <strong>(OSAHS)</strong>. The ideal therapy is <strong>continuous positive airway pressure therapy (CPAP).</strong></p>\n<p>Option A: Supplemental oxygenation can improve oxygen saturation but there is little evidence that it improves OSAHS symptoms.</p>\n<p>Option B: Uvulopalatopharyngoplasty is the most common surgery done in OSAHS but it is reserved for patients who cannot tolerate CPAP.</p>\n<p>Option D: Unilateral neuro-stimulation of the hypoglossal nerve through a surgically implanted device is a recently tested therapy for OSAHS. It can be used as an alternative in selected patients who cannot tolerate CPAP.</p><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;The FDA recently authorized eXciteOSA, a new prescription-only device to reduce snoring &amp; mild obstructive sleep apnea. This is the first device used while awake that is intended to improve tongue muscle function, which in time helps prevent the tongue from collapsing backwards and obstructing the airway during sleep.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:33555261,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;11&quot;:4,&quot;12&quot;:0,&quot;28&quot;:1}\">The FDA recently authorized <strong>eXciteOSA</strong>, a new prescription-only device to reduce snoring &amp; mild obstructive sleep apnea. This is the first device used while awake that is intended to improve tongue muscle function, which in time helps prevent the tongue from collapsing backwards and obstructing the airway during sleep.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2703",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a component of Syndrome Z?",
      "choices": [
        {
          "id": 1,
          "text": "Obstructive sleep apnea"
        },
        {
          "id": 2,
          "text": "Blood pressure more than 130/85 mmHg"
        },
        {
          "id": 3,
          "text": "Fasting triglyceride more than150mg/dl"
        },
        {
          "id": 4,
          "text": "LDL more than 100mg/dl"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Syndrome</strong> <strong>Z</strong> is defined as a combination of obstructive sleep apnea syndrome with metabolic&nbsp;syndrome.&nbsp;LDL more than 100 mg/dL&nbsp;is not a criterion for the diagnosis of metabolic&nbsp;syndrome.</p>\n<p><strong>Metabolic syndrome</strong> is diagnosed based on <strong>The NCEP: ATP III Criteria</strong>. <strong>Three or more</strong> of the following must be present :</p>\n<ul>\n<li><strong>Central obesity</strong>: waist circumference &gt;102 cm (M), &gt;88 cm (F)</li>\n<li><strong>Hypertriglyceridemia</strong>: triglyceride level &ge;150 mg/dL or specific medication</li>\n<li><strong>Low HDL</strong> cholesterol: &lt;40 mg/dL and &lt;50 mg/dL for men and women, respectively, or specific medication</li>\n<li><strong>Hypertension</strong>: blood pressure &ge;130 mmHg systolic or &ge;85 mmHg diastolic or specific medication</li>\n<li><strong>Fasting</strong> plasma glucose level <strong>&ge;100 mg/dL</strong> or specific medication or previously diagnosed type 2 diabetes</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5298",
      "difficulty": "medium"
    }
  ]
}